| Novartis' Galvus gets new European approval - PMLiVE |
|
|
PMLiVE The drug was previously limited to patients with no or mild renal impairment, which is when the kidneys fail to filter toxins and waste products from the blood and can be a common cause of death in people with diabetes. Few treatment options are ... Novartis drug Galvus® approved in EU for type 2 diabetes patients with |